# Scandinavian Candesartan Acute Stroke Trial (SCAST)

> **NCT00120003** · PHASE3 · COMPLETED · sponsor: **Ullevaal University Hospital** · enrollment: 2500 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Candesartan Cilexetil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00120003
- **Lead sponsor:** Ullevaal University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2011-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120003, "Scandinavian Candesartan Acute Stroke Trial (SCAST)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00120003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*